Mainstay Capital Management’s GSK GSK Stock Holding History

Mainstay Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-24,673	Closed	-$1.16M	–	113
2020 Q3	$1.16M	Sell	24,673 -2,556	-9%	-$128K	0.3%	50
2020 Q2	$1.39M	Sell	27,229 -1,232	-4%	-$63.2K	0.4%	43
2020 Q1	$1.34M	Sell	28,461 -1,892	-6%	-$101K	0.43%	26
2019 Q4	$1.78M	Buy	+30,353	New	+$1.69M	0.41%	32
2018 Q4	–	Sell	-837	Closed	-$42K	–	203
2018 Q3	$42K	Buy	837 +82	+11%	+$4.17K	0.03%	218
2018 Q2	$38K	Hold	755	–	–	0.03%	203
2018 Q1	$36K	Buy	755 +375	+99%	+$17.5K	0.03%	176
2017 Q4	$17K	Buy	+380	New	+$17.6K	0.01%	231

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Mainstay Capital Management's GSK Position: Q4 2020 in Review

Mainstay Capital Management sold out of GSK (GSK) in Q4 2020, closing a stake of 24,673 shares — an estimated $1.16M sold.

Mainstay Capital Management first reported a position in GSK in Q4 2017 and held it in 8 quarters. The position peaked at $1.78M in Q4 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Mainstay Capital Management reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Mainstay Capital Management sold 24,673 GSK shares in Q4 2020, an estimated $1.16M.
Mainstay Capital Management first reported a position in GSK in Q4 2017 and held it in 8 quarters.
Mainstay Capital Management's GSK position peaked at $1.78M in Q4 2019.
818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Mainstay Capital Management's 13F filing for Q4 2020, filed 4 Mar 2021.